Tassinari, Davide <br/><br/>
Second line treatments in advanced platinum-resistant non small cell lung cancer. A critical review of literature.  [electronic resource] 

 -  Reviews on recent clinical trials  Jan 2009 
 - 27-33 p.  digital 
<br/><br/> Publication Type: Journal Article; Review; Systematic Review 
<br/><br/><label>ISSN: </label>1574-8871 
<br/><br/><label>Standard No.: </label>10.2174/157488709787047549  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--administration & dosage<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Clinical Trials, Phase III as Topic<br/>Docetaxel<br/>Drug Administration Schedule<br/>ErbB Receptors--antagonists & inhibitors<br/>Erlotinib Hydrochloride<br/>Gefitinib<br/>Glutamates--administration & dosage<br/>Guanine--administration & dosage<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Pemetrexed<br/>Protein Kinase Inhibitors--administration & dosage<br/>Quinazolines--administration & dosage<br/>Randomized Controlled Trials as Topic<br/>Taxoids--administration & dosage<br/>Treatment Outcome